Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels

International Archives of Allergy and Immunology

Volumn 152, Issue 4, 2010, Pages 390-400

  Schmetterer, Klaus G ^a   Seidel, Markus G ^b   Körmöczi, Ulrike ^a   Rottal, Arno ^a   Schwarz, Klaus ^d   Matthes Martin, Susanne ^b   Steinberger, Peter ^a   Pickl, Winfried F ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c INSTITUTE FOR MICROELECTRONICS   (Austria)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

HLA class II deficiency; Immunodeficiency; Invariant chain; MHC II deficiency; Superantigens

Indexed keywords

BLOOD CLOTTING FACTOR 10; COMPLEMENTARY DNA; HLA ANTIGEN CLASS 2; INVARIANT CHAIN PROTEIN; PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANALYSIS; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL LINE; CLINICAL FEATURE; CLINICAL TRIAL; CODON; COMBINED IMMUNODEFICIENCY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GENE DELETION; GENE MUTATION; HOMOZYGOSITY; HUMAN; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RAPID VECTOR BASED COMPLEMENTATION ANALYSIS;

ADULT; AGAMMAGLOBULINEMIA; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LYMPHOPENIA; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; SUPERANTIGENS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 77449088545     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288292     Document Type: Article

References (36)

1. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-299.
2. Ting JP, Baldwin AS: Regulation of MHC gene expression. Curr Opin Immunol 1993; 5: 8-16.
3. Glimcher LH, Kara CJ: Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10: 13-49.
4. Mach B, Steimle V, Martinez-Soria E, Reith W: Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol 1996; 14: 301-331.
5. Reith W, Mach B: The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 2001; 19: 331-373.
6. Nekrep N, Fontes JD, Geyer M, Peterlin BM: When the lymphocyte loses its clothes. Immunity 2003; 18: 453-457.
7. Waldburger JM, Masternak K, Muhlethaler- Mottet A, Villard J, Peretti M, Landmann S, Reith W: Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression. Immunol Rev 2000; 178: 148-165.
8. Reith W, Lisowska-Grospierre B, Fischer A: Molecular Basis of Major Histocompatibility Complex Class II Deficiency, ed 2. New York, Oxford University Press, 2007.
9. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C: Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 1993; 123: 921-928.
10. Steimle V, Otten LA, Zufferey M, Mach B: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135-146.
11. Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W: A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 1998; 20: 273-277.
12. Nagarajan UM, Louis-Plence P, DeSandro A, Nilsen R, Bushey A, Boss JM: RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 1999; 10: 153-162.
13. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W: A novel DNAbinding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 1995; 9: 1021-1032.
14. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W: RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J 1997; 16: 1045-1055.
15. Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF, Stockl J, Knapp W: Molecular characterization of human 4Ig- B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 2004; 172: 2352-2359.
16. Derdak SV, Kueng HJ, Leb VM, Neunkirchner A, Schmetterer KG, Bielek E, Majdic O, Knapp W, Seed B, Pickl WF: Direct stimulation of T lymphocytes by immunosomes: virus- like particles decorated with T cell receptor/ CD3 ligands plus costimulatory molecules. Proc Natl Acad Sci USA 2006; 103: 13144-13149.
17. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
18. Quan V, Towey M, Sacks S, Kelly AP: Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA. Immunogenetics 1999; 49: 957-963.
19. Bontron S, Steimle V, Ucla C, Eibl MM, Mach B: Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum Genet 1997; 99: 541-546.
20. Mannhalter JW, Wolf HM, Gadner H, Potschka M, Eibl MM: Cell-mediated immune functions in a patient with MHC class II deficiency. Immunol Invest 1991; 20: 151-167.
21. Fondaneche MC, Villard J, Wiszniewski W, Jouanguy E, Etzioni A, Le Deist F, Peijnenburg A, Casanova JL, Reith W, Mach B, Fischer A, Lisowska-Grospierre B: Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet 1998; 7: 879-885.
22. Villard J, Lisowska-Grospierre B, van den Elsen P, Fischer A, Reith W, Mach B: Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N Engl J Med 1997; 337: 748-753.
23. Rocha N, Neefjes J: MHC class II molecules on the move for successful antigen presentation. EMBO J 2008; 27: 1-5.
24. Tai AK, Zhou G, Chau K, Ono SJ: Cis-element dependence and occupancy of the human invariant chain promoter in CIITA-dependent and -independent transcription. Mol Immunol 1999; 36: 447-460.
25. Matheux F, Ikinciogullari A, Zapata DA, Barras E, Zufferey M, Dogu F, Regueiro JR, Reith W, Villard J: Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. Mol Ther 2002; 6: 824-829.
26. Piirila H, Valiaho J, Vihinen M: Immunodeficiency mutation databases (IDbases). Hum Mutat 2006; 27: 1200-1208.
27. Zhou H, Glimcher LH: Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 1995; 2: 545-553.
28. Chang CH, Fontes JD, Peterlin M, Flavell RA: Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367-1374.
29. Peijnenburg A, Van Eggermond MJ, Gobin SJ, Van den Berg R, Godthelp BC, Vossen JM, Van den Elsen PJ: Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5. J Immunol 1999; 163: 794-801.
30. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R: MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-1476.
31. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R: CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006; 25: 595-606.
32. Chang CH, Flavell RA: Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181: 765-767.
33. Masternak K, Reith W: Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation. EMBO J 2002; 21: 1379-1388.
34. Nagarajan UM, Peijnenburg A, Gobin SJ, Boss JM, van den elsen PJ: Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J Immunol 2000; 164: 3666-3674.
35. Peijnenburg A, Van Eggermond MC, Van den Berg R, Sanal O, Vossen JM, Van den Elsen PJ: Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 1999; 49: 338-345.
36. Hoffman R, Benz EJ, Shattil S, Furie B, Cohen HJ, Silberstein LE, McGlave P: Hematology: Basic Principles and Practice, ed 3. Philadelphia, Churchill Livingstone, 2000.